Fresenius SE KGaA (XTER:FRE) Net Income From Continuing Operations : €238 Mil (TTM As of Dec. 2023)

View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Fresenius SE KGaA's net income from continuing operations for the three months ended in Dec. 2023 was €-217 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was €238 Mil.

Fresenius SE KGaA Net Income From Continuing Operations Historical Data

The historical data trend for Fresenius SE KGaA's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Net Income From Continuing Operations Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

3,029.00

2,823.00

2,819.00

1,222.00

238.00

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Income From Continuing Operations	Get a 7-Day Free Trial															209.00	463.00	166.00	-174.00	-217.00

Fresenius SE KGaA Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €238 Mil.

Fresenius SE KGaA (XTER:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

FSNUY:USA FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Executives

Dr. Michael Moser	Board of Directors
Sara Hennicken	Board of Directors
Michael Sen	Board of Directors
Dr. Francesco De Meo	Board of Directors
Stephan Sturm	Board of Directors
Wolfgang Kirsch	Supervisory Board
Mats Henriksson	Board of Directors
Dr. Gerd Krick	Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines